Incyte Corp
(NAS:INCY)
$
129.88
+11 (+9.25%)
Market Cap: 25.95 Bil
Enterprise Value: 21.97 Bil
PE Ratio: 18.34
PB Ratio: 4.62
GF Score: 86/100 
Incyte Corp at Leerink Global Healthcare Conference Transcript
Mar 10, 2026 / 01:20PM GMT
Release Date Price:
$96.02
(-1.07%)
Andrew Berens
Leerink Partners LLC - Analyst
Good morning, everyone. I'm Andy Berens, Senior Biotech Analyst at Leerink Partners, on day two of our Global Healthcare Conference in Miami. We're very happy to have with us Incyte. We have Pablo and Bill.
Thank you, gentlemen, for joining us.
Pablo Cagnoni
Incyte Corp - President - Research and Development
Thank you for having us.
Bill Meury
Incyte Corp - President, Chief Executive Officer, Director
It's good to be here
Andrew Berens
Leerink Partners LLC - Analyst
Yeah, it's beautiful weather.
Questions & Answers
Andrew Berens;
Leerink Partners LLC - Analyst
Why don't we start? I mean, obviously I think a lot of people know Incyte, but maybe just a general overview. I mean, you assumed the helm recently, and maybe we could talk a little bit about how the company --- what's changed and what's remained the same, I guess, since you joined.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers